CH 275 (acetate) |
| رقم الكتالوجGC91848 |
CH 275 is a cyclic peptide agonist of somatostatin receptor 1 (SST1; IC50 = 30.9 nM for the human receptor).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CH 275 is a cyclic peptide agonist of somatostatin receptor 1 (SST1; IC50 = 30.9 nM for the human receptor).[1] It is selective for SST1 over SST2, SST3, SST4, and SST5 (IC50s = >10,000, 345, >1,000, and >10,000 nM, respectively, for the human receptors). CH 275 (500 nM) inhibits basal growth hormone secretion from primary mouse pituitary cells.[2] It inhibits glucose-induced increases in electrical activity without inducing membrane hyperpolarization in a whole-cell patch-clamp assay using MIN6 pancreatic β-cells when used at a concentration of 100 nM.[3]
References:
[1].Rivier, J.E., Hoeger, C., Erchegyi, J., et al.Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1)J. Med. Chem.44(13)2238-2246(2001).
[2].Kreienkamp, H.J., Akgün, E., Baumeister, H., et al.Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophsFEBS Lett.462(3)464-466(1999).
[3].Smith, P.A., Sellers, L.A., and Humphrey, P.P.Somatostatin activates two types of inwardly rectifying K+ channels in MIN-6 cellsJ. Physiol.532(Pt 1)127-142(2001).
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *